Bengt Liljas

Dr. Bengt Liljas

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2000 in Health Policy
Verified
Journal Article
Closed access
BLBengt Liljas
Bengt Liljas
KBKaren Blumenschein
Karen Blumenschein

1 January 2001 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
BLBengt Liljas
Bengt Liljas
BLBjörn Lindgren
Björn Lindgren

5 September 2007 in Health Economics
Verified
Journal Article
Closed access
PDF file
BLBengt Liljas
Bengt Liljas
GKGöran S. Karlsson
Göran S. Karlsson
NSNils‐Olov Stålhammar
Nils‐Olov Stålhammar

10 April 2023 in Expert Review of Pharmacoeconomics & Outcomes Research
Verified
Journal Article
Open access
TMTalha Munir
Talha Munir
VGVictor Genestier
Victor Genestier
KRKellie Ryan
Kellie Ryan
BLBengt Liljas
Bengt Liljas
PGPriyanka Gaitonde
Priyanka Gaitonde
Clinical outcomes in chronic lymphocytic leukemia (CLL) have improved with targeted therapy, including Bruton tyrosine kinase inhibitors such as acalabrutinib.A semi-Markov model with 3 health stat...

3 March 2009 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
BLBengt Liljas
Bengt Liljas